搜索临床试验以:多西紫杉醇、曲妥珠单抗和 MM-111
总计5946个结果
-
Merrimack Pharmaceuticals终止
-
Merrimack Pharmaceuticals完全的
-
AO Clinical Investigation and Publishing Documentation完全的
-
Merrimack Pharmaceuticals完全的
-
Elevation OncologyMerrimack Pharmaceuticals终止
-
Elevation Oncology终止
-
Aldagen终止
-
Ankyra Therapeutics, Inc招聘中
-
Aardvark Therapeutics, Inc.Children's Hospital Colorado; Stanford University招聘中
-
Merrimack PharmaceuticalsSanofi完全的
-
Merrimack PharmaceuticalsSanofi完全的
-
Fondation Hôpital Saint-Joseph尚未招聘
-
Merrimack PharmaceuticalsSanofi完全的
-
Aardvark Therapeutics, Inc.University of California, San Diego完全的
-
Pamela Munster撤销晚期实体瘤 | 脑转移 | 记录在案的 Her2 过度表达 | 神经稳定
-
Merrimack PharmaceuticalsSanofi完全的
-
Merrimack Pharmaceuticals终止
-
European Organisation for Research and Treatment...GlaxoSmithKline完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; Cephalon完全的
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis Pharmaceuticals终止
-
Biocon Biologics UK Ltd尚未招聘HR 阴性 HER2 阳性早期乳腺癌或局部晚期乳腺癌患者
-
Cancer Trials Ireland完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Merrimack Pharmaceuticals完全的
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.主动,不招人
-
Peking University People's Hospital招聘中
-
Intergroupe Francophone de Cancerologie Thoracique完全的
-
King Faisal Specialist Hospital & Research Center完全的